
Hims & Hers Telehealth Clone For LatAm
Draft
About
This is essentially a Hims & Hers regional expansion playbook for Latin America — a proven model in a massive, underserved market. The opportunity is real, but execution is brutally hard: pharmacy licensing in 5+ countries, fragmented regulation, and local incumbents mean you're signing up for a multi-year regulatory gauntlet with heavy capital requirements before you see scale.
Modeled valuation
$15M ARR · 6.6× ARR (HealthTech) · Range $74M–$134M
HealthTech baseline 5.5×, adjusted to 6.6× (+0.1× strong idea score (58/100); +2× exceptional Y2→Y3 growth (>150%); −1× high execution complexity (8/10))
Market
Revenue
Difficulty
diego_morales
Founder
Idea Portfolio
$146.0M
across 3 ideas
AI-modeled estimate · 6.6× ARR (HealthTech) on $15M ARR. Not a guarantee.
Comments